282
Views
2
CrossRef citations to date
0
Altmetric
Articles

Reasons of relapse and pattern of drug use among the substance users in Bangladesh: A nationwide study

, , , , , & ORCID Icon show all
 

Abstract

This study aimed at investigating the reasons of relapse and patterns of drug use among the substance users in Bangladesh. We have conducted a descriptive type of cross-sectional study among the relapse cases of substances users in the whole of Bangladesh. Concerning the reasons for relapse after taking treatment; family unrest (29.5%), peer pressure (27.4%), to reduce depression (24.8%) and craving for drugs (24.3%) were the most frequent. Amphetamine was reported to be the most used drug (76.1%, n = 693), followed by cannabis (75%, n = 683) and alcohol (54.3%, n= 495). Further extensive studies are also needed to explore the association.

Acknowledgement

We would like to express our sincere thanks and gratitude to the authorities of rehabilitation centers for their kind cooperation and support during study period. We are also thankful to the management board of Dhaka Ahsania Mission for providing funds to conduct this important nationwide survey.

Data availability statement

The datasets used in the current study are available from the corresponding author on reasonable request.

Disclosure statement

The author(s) declare that there are no conflicts of interest in any steps of this research.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.